These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 37995374)
41. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells. Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548 [TBL] [Abstract][Full Text] [Related]
42. m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-β-induced epithelial-mesenchymal transition of lung cancer cells. Suphakhong K; Terashima M; Wanna-Udom S; Takatsuka R; Ishimura A; Takino T; Suzuki T J Biol Chem; 2022 Nov; 298(11):102554. PubMed ID: 36183833 [TBL] [Abstract][Full Text] [Related]
43. RNA methylomes reveal the m Zhou L; Tian S; Qin G Genome Biol; 2019 Aug; 20(1):156. PubMed ID: 31387610 [TBL] [Abstract][Full Text] [Related]
44. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma. Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030 [TBL] [Abstract][Full Text] [Related]
45. Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells. Ghazi T; Nagiah S; Chuturgoon AA Epigenetics; 2021 Jan; 16(1):79-91. PubMed ID: 32631113 [TBL] [Abstract][Full Text] [Related]
46. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738 [TBL] [Abstract][Full Text] [Related]
47. METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA. Wu Z; Shi Y; Lu M; Song M; Yu Z; Wang J; Wang S; Ren J; Yang YG; Liu GH; Zhang W; Ci W; Qu J Nucleic Acids Res; 2020 Nov; 48(19):11083-11096. PubMed ID: 33035345 [TBL] [Abstract][Full Text] [Related]
48. N6-methyladenosine (m6A) modification in gynecological malignancies. Zhang C; Liu N J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474 [TBL] [Abstract][Full Text] [Related]
49. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262 [TBL] [Abstract][Full Text] [Related]
50. Identification and functional annotation of m6A methylation modification in granulosa cells during antral follicle development in pigs. Cao Z; Zhang D; Wang Y; Tong X; Avalos LFC; Khan IM; Gao D; Xu T; Zhang L; G Knott J; Zhang Y Anim Reprod Sci; 2020 Aug; 219():106510. PubMed ID: 32828396 [TBL] [Abstract][Full Text] [Related]
51. Comprehensive Analysis and Functional Characteristics of Differential Expression of N6-Methyladenosine Methylation Modification in the Whole Transcriptome of Rheumatoid Arthritis. Wan L; Liu J; Huang C; Zhu Z; Wang K; Sun G; Zhu L; Hu Z Mediators Inflamm; 2022; 2022():4766992. PubMed ID: 36330380 [TBL] [Abstract][Full Text] [Related]
52. The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer. Shi B; Liu WW; Yang K; Jiang GM; Wang H Mol Cancer; 2022 Aug; 21(1):163. PubMed ID: 35974338 [TBL] [Abstract][Full Text] [Related]
53. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology. Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507 [TBL] [Abstract][Full Text] [Related]
54. m6A RNA methylation of major satellite repeat transcripts facilitates chromatin association and RNA:DNA hybrid formation in mouse heterochromatin. Duda KJ; Ching RW; Jerabek L; Shukeir N; Erikson G; Engist B; Onishi-Seebacher M; Perrera V; Richter F; Mittler G; Fritz K; Helm M; Knuckles P; Bühler M; Jenuwein T Nucleic Acids Res; 2021 Jun; 49(10):5568-5587. PubMed ID: 33999208 [TBL] [Abstract][Full Text] [Related]
55. Maternal obesity increases DNA methylation and decreases RNA methylation in the human placenta. Shen WB; Ni J; Yao R; Goetzinger KR; Harman C; Reece EA; Wang B; Yang P Reprod Toxicol; 2022 Jan; 107():90-96. PubMed ID: 34890771 [TBL] [Abstract][Full Text] [Related]
56. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential. Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065 [TBL] [Abstract][Full Text] [Related]
57. Role of DNA and RNA N6-Adenine Methylation in Regulating Stem Cell Fate. Wu Y; Zhou C; Yuan Q Curr Stem Cell Res Ther; 2018; 13(1):31-38. PubMed ID: 28637404 [TBL] [Abstract][Full Text] [Related]
58. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism. Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731 [TBL] [Abstract][Full Text] [Related]
59. Role of N6-methyladenosine modification in pathogenesis of ischemic stroke. Chang H; Yang J; Wang Q; Zhao J; Zhu R Expert Rev Mol Diagn; 2022 Mar; 22(3):295-303. PubMed ID: 35236212 [TBL] [Abstract][Full Text] [Related]
60. Epitranscriptomic m6A regulation following spinal cord injury. Xing L; Cai Y; Yang T; Yu W; Gao M; Chai R; Ding S; Wei J; Pan J; Chen G J Neurosci Res; 2021 Mar; 99(3):843-857. PubMed ID: 33271625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]